1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

CAYENNE WHO?

Discussion in 'Arthrex' started by Anonymous, Jun 13, 2014 at 9:32 PM.

  1. Anonymous

    Anonymous Guest

    Cayenne Medical just showed up in my territory. Has anyone any comments on this competitor?
     
  2. Anonymous

    Anonymous Guest

    I heard they had a few unique products, not much else.
     
  3. Anonymous

    Anonymous Guest

    Stupid statement!
     
  4. Anonymous

    Anonymous Guest

    "STUPID IS AS STUPID DOES!!!
     
  5. Anonymous

    Anonymous Guest

    Never heard of them
     
  6. Anonymous

    Anonymous Guest

    acl device is novel but over priced and mgmt thinks too highly of it to bend on pricing - at their own peril. they have burned through so many distributors in my area it's not funny. and I hear that's the case elsewhere as well. have seen multiple anchors break upon insertion. overall the company is weak. been around a long time now and have never been able to gain real traction.
     
  7. Anonymous

    Anonymous Guest

    Thank you for the response.